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Abstract
PET relative metabolism was correlated with quantitative EEG in 9 schizo-
phrenic patients. The PET metabolic regions of interest were the frontal lobes,
thalamus and basal ganglia, and right and left temporal lobes. Significant posi-
tive correlations were seen for the frontal lobes and delta EEG power, and
alpha power with subcortical metabolism. The physiologic plausibility of
those correlations is discussed with reference to the possible effect of neurolep-
tic medication.
OOOOOOOOOOOOOOOOOOOOOO
Introduction
The correlation of the EEG and metabolism may pro-
vide a heuristically useful approach to the question of the
generation of the EEG. Electrophysiologic measurements
obtained from the scalp are direct consequences of the fir-
ing and membrane potential shifts of populations of neu-
rons, events which require metabolic energy. It therefore
seems reasonable to expect that electrophysiology and
metabolism are correlated and this correlation may con-
tribute some understanding to the generation of the
EEG.
A common finding in studies correlating metabolism
or regional cerebral bloodflow (rCBF) with quantitative
EEG (qEEG) is a significant negative correlation of qEEG
slow activity to metabolism or rCBF. However, a simple
correlation between qEEG mean frequency content and
rCBF or metabolism appears to be more characteristic of
states of frank neurologic pathology such as primary
dementia or cerebrovascular disease. Across four studies
making comparisons between healthy controls and de-
mentia patients [1, 2], or between hemispheres in the
presence of a unilateral infarct [3, 4], the variance of
qEEG explained by rCBF or metabolism was relatively
greater either in the demented subjects or the infarcted
hemisphere. The limited investigations that have re-
ported on normals or schizophrenics suggest the lack of a
simple relationship or qEEG frequency content to metab-
olism. Buchsbaum et al. [5] found both positive and nega-
tive correlations with either delta or alpha power to posi-
tron emission tomography (PET) metabolism in normals
in the eyes closed resting state depending on which topo-
graphic region was examined. In a subsequent report on
schizophrenics [6], PET metabolism measured during a
continuous performance task correlated negatively with
frontal EEG delta power during the task, and positively
with occipital EEG delta power at rest.
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Table 1. Patient characteristics
Patient
No.
Age
years
Education
years
Diagnosis Duration
of illness
years
Medication BPRS AIMS
PET and
EEG
Interval
(days)
between
1 33 12 Undifferentiated 20 Off 42 0 1a
2 32 12 Paranoid 10 On 32 12 7b
3 36 11 Paranoid 15 On 22 0 7b
4 28 9 Undifferentiated 9 On 24 6 7b
5 22 10 Paranoid 5 Off 37 0 1b
6 43 6 Disorganized 20 On 32 1 6b
7 27 11 Undifferentiated 11 On 30 0 1a
8 35 12 Paranoid 9 On 26 0 1a
9 33 13 Disorganized 14 On 36 18 1a
a These patients were studied with qEEG once, 1 day after their PET study.
b There patients were studied with qEEG twice; simultaneously with PET study and again subsequent to the PET
study.
The opportunity to observe correlations between rest-
ing EEG and PET metabolism in schizophrenics arose in
the context of a study of the metabolic correlates of a
motor task in schizophrenia that has been published else-
where [7]. As this study involved PET measurements
obtained at rest in schizophrenics, it was possible to also
additionally obtain resting EEG measurements. This
present study reports on the correlation of qEEG and PET
in a sample of 9 schizophrenics. One objective of this pre-
liminary investigation was to examine the topography of
PET and qEEG correlations. In addition, it was also pos-
sible to examine the question of the possible effect of the
PET laboratory environment on the qEEG by obtaining
EEG from the same subjects simultaneously with the PET
scan, and again subsequently in the environment of the
EEG laboratory.
Subjects and Methods
Nine patients meeting DSM-III-R and RDC criteria for schizo-
phrenia were studied in this investigation with PET and EEG. These
subjects are a subset of those reported in Günther et al. [7]. Subject
characteristics are summarized in table 1. Seven subjects were on
neuroleptic medication at the time of the study, in all medicated
patients the neuroleptic medication used was haloperidol in either
the oral or decanoate form with oral dosages ranging from 10 to
40 mg per day and 1 patient on haloperidol 10 mg per day and deca-
noate 150 mg every 4 weeks. Two subjects had been off medication
for at least 1 year prior to the study. No other psychotropic medica-
tion had been used for at least 1 month prior to the study, with the
exception of benzodiazepine hypnotics which were withheld the
night prior to the study. Subjects with histories of substance abuse,
head trauma with loss of consciousness, encephalitis, or other neuro-
logic conditions known to affect the EEG were excluded from the
study. Ratings on the Brief Psychiatric Rating Scale (BPRS) [8] and
Abnormal Involuntary Movement Scale (AIMS) [9] were obtained
the day prior to the PET study.
For 5 of the 9 subjects EEG and PET were obtained simulta-
neously in real time at the Brookhaven National Laboratory. Addi-
tionally, EEG data was obtained on all 9 subjects subsequent to the
PET scan at Brain Research Laboratories at New York University
Medical Center. The interval between the PET study with or without
EEG simultaneous at Brookhaven, and the EEG study at Brain
Research Laboratories are provided in table 1. For the 5 subjects on
whom EEG simultaneous was available, the EEG obtained simulta-
neously with PET was used to compute PET/EEG correlations. In the
4 subjects without simultaneous EEG, the EEG obtained at Brain
Research Laboratories subsequent to the PET scan was used. To
address the question of the reliability between EEG simultaneous
with PET and EEG obtained subsequent to the PET scan, test-retest
comparisons were examined for EEG on subjects for whom both
simultaneous and nonsimultaneous EEG data were available. As
seen in figure 1, the test-retest comparisons showed generally good
replicability of EEG obtained during the PET scan and EEG subse-
quent to the PET scan.
EEG Data Acquisition
EEG data were collected using 19 electrodes placed in accordance
with the International 10/20 system, referenced to linked earlobes.
All electrode impedances were less than 5,000 ø. Amplifier band-
width was from 0.5 to 70 Hz (3 dB points), with a 60-Hz notch filter;
sampling rate was 200 Hz.
Data Analysis
EEG Feature Extraction. The neurometric EEG feature extrac-
tion methods used have been described in detail previously [10]. One
to two minutes of artifact-free data were extracted from the EEG
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Fig. 1. Test-retest EEG data on 5 subjects evaluated simulta-
neously with PET scanning and again subsequently a mean of 5.6
days later in the EEG lab.
recorded for quantitative analysis, with the aid of a computerized
artifact detection algorithm. All epochs selected for analysis were
visually reviewed by one of the authors to exclude any artifacts which
eluded this algorithm. Univariate features were computed for abso-
lute and relative power, coherence and asymmetry in four frequency
bands (delta, 1.5–3.5 Hz; theta, 3.5–7.5 Hz; alpha, 7.5–12.5; beta,
12.5–25 Hz) for the 19 monopolar derivations. Each feature was
compared with normative age-regression equations to obtain Z
scores, after transformations to ensure Gaussianity.
PET Scan Procedures
All subjects were scanned in the low-resolution mode on the PET
VI at Brookhaven National Laboratory (spatial resolution at full
width of half-maximum = 11.8 mm in the plane of section and
14.4 mm in the axial direction). Prior to the first isotope injection
each subject’s head was positioned in a plane parallel to the canthom-
eatal line. Transmission scans were the performed using a 68Ge/68Ga
ring source. These were used for attenuation correction and to define
the size and center of the brain for each PET image. Catheters were
inserted into a dorsal vein for isotope administration 45 min before
the first injection. Each subject’s left hand was heated to maintain
skin temperature 44 °C in order to arterialize venous blood [11].
The plasma input function was determined for multiple sampling
of the arterialized blood prior to and for 35 min after injection of the
11C-2-deoxyglucose (CDG). Each subject received an injection of a
bolus of between 5.8 and 6.5 mCi of CDG each [12], administered at
approximately 10.30 a.m. Scans were obtained at 35 min and again
at 45 min after injection. Seven simultaneous images were obtained
from each scan. After the 35-min scan the subject was moved
7.2 min, which resulted in a set of 14 interleaved PET images slightly
displaced in time. Calculation of the normalized regional metabolic
rates of glucose metabolism was performed as previously described
in Bartlett et al. [13]. The calculation of normalized regional meta-
bolic rates by this method yields measures that have been demon-
strated to be highly reproducible on the order of 1%.
Regions of interest (ROIs) were obtained from nine contiguous
images located between approximately 10.3 and 4.7 cm above the
canthomeatal line. MRI or CT images from approximately the same
planes of section were transferred by computer software onto corre-
sponding metabolic images. The ROIs utilized in this paper are
derived from those utilized by Günther et al. and are composites that
subsume the smaller ROIs presented in Günther et al. [7]. In the
present study ‘frontal’ combines the mesial frontal region anterior to
the central sulcus, and the right prefrontal and left prefrontal regions.
‘Subcortical’ combines the right and left thalamus and basal ganglia,
and ‘right temporal’ and ‘left temporal’ are the same as the corre-
spondingly named ROIs in Günther et al. [7]. A detailed figure illus-
trating the boundaries of those ROIs utilized by Günther et al. [7] is
available in that paper.
Correlations between PET ROIs and neurometric Z scores were
computed using the Pearson r. For n = 9 (d.f. = 7), at p = 0.05, r =
0.67.
Results
Figure 1 shows the test-retest comparison for EEG
obtained on 5 subjects during PET scan, and then subse-
quent to the PET scan at the EEG lab. The issue of test-
retest reliability between qEEG measures is relevant to
the validity of including the 4 subjects without EEG
obtained simultaneously with PET in the calculation of
PET/EEG correlations. The test-retest interval for EEG
on the 5 subjects obtained during and after the PET scan
was 5.6 (range 1–7) days. The test-retest interval for each
of the other 4 subjects whose EEG was only obtained sub-
sequent to PET was 1.0 B 0 days.
As is evident from figure 1, there is little change in
qEEG values for the 5 subjects examined both simulta-
neously with and subsequent to PET. The apparent lack
of change indicates that there is little difference between
qEEG values obtained under the conditions and environ-
ment of the PET scan and a mean of 5.6 days later in the
EEG lab. The time interval between PET and retest qEEG
in these 5 subjects is greater than the 1 day separating the
PET and EEG studies of the other 4 subjects. It can be
argued, therefore, that the test-retest results for the 5 sub-
jects with EEG in both states is conservative in providing
evidence for the validity of including EEG data obtained
from the other subjects whose EEG was obtained only
subsequent to the PET study.
Figure 2 shows maps of the correlations between rela-
tive PET metabolism in each of 4 PET ROIs and qEEG
for all 9 subjects. The correlations for relative power are
divided into the delta, theta, alpha and beta bandwidths,
and the correlations with mean frequency are for the
entire frequency spectrum of 1.5–25 Hz. The PET ROIs,
each of which is correlated separately with the 4 relative
power measures and 1 overall EEG frequency measure,
are frontal, subcortical, and left and right temporal (see
PET methodology).
For the delta bandwidth, there is an apparently posi-
tive correlation with the frontal PET ROI in anterior
leads. There is generally negative correlation of relative
delta power with subcortical metabolism. For the cortical
PET ROIs (frontal, left temporal and right temporal)
there is a general topographic pattern of positive correla-
tions anteriorly and negative correlations posteriorly. The
topography of correlations of relative theta power shows a
rough similarity to those for relative delta power.
For the alpha relative power bandwidth, there is a gen-
eral topographic pattern of PET/qEEG correlation that is
the inverse of that for delta and theta. The cortical PET
regions generally correlate negatively with relative alpha
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Fig. 2. Correlations of each of the 4 PET ROIs with absolute and relative power in the delta, theta, alpha, and beta
bandwidths, and mean frequency across the frequency spectrum of 1.5–25 Hz.
anteriorly and positively posteriorly. Beta relative power
tends to correlate negatively with all PET ROIs, however
the magnitude of most correlations is low.
The values for overall mean frequency tend to conform
with the expectation that would be derived from inspec-
tion of the maps for delta and alpha. Where alpha tends to
correlate positively with PET, mean frequency also tends
to correlate positively with PET. Where PET and delta
relative power correlated positively, the correlations for
mean frequency and PET tend to be negative.
Discussion
The results presented in figure 1 indicate good test-
retest reliability between qEEG measures obtained simul-
taneously with PET and those obtained subsequent to
PET in the EEG lab. These results are consistent with pre-
vious work on the test-retest reliability of the qEEG [14–
16]. The neurometric methodology may be particularly
helpful in this regard. The normative data, from which the
confidence limits of neurometrics Z scores are derived,
intentionally does not control for certain factors and
treats them as normal variance. For example, the normal
subjects in the neurometric data base were tested without
controlling rigorously for time of day and at several differ-
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ent sites. Such an approach increases the confidence lim-
its of the normal data which mitigates against falsely posi-
tive values deriving from overly rigid or specific testing
parameters. The multiple replications of the neurometric
norms [17–22] provide substantiative empirical justifica-
tion for this approach. In the present study, the inclusion
of the incidental effects of differing laboratory environ-
ments in the confidence limits of the norms against which
the qEEG data was referenced may have mitigated
against spurious changes due to laboratory environment.
The test-retest reliability of the data obtained from the 5
subjects simultaneous and subsequent to PET supports
the validity of having included the other 4 subjects whose
data was only obtained subsequent to PET.
One result that might be viewed as somewhat surpris-
ing is that a positive relationship was seen between frontal
PET metabolism and relative delta qEEG power. The well
known entity of pathological polymorphic delta has been
correlated with anoxia and functional deafferentation of
the cortex [23, 24], and often leads to the assumption of a
general association of delta activity with depressed cere-
bral metabolism. However, approximately 20–30% of the
voltage of awake normal humans in anterior leads is in
delta as revealed by multiple replicated studies [17–22].
Increased delta activity has been correlated with a num-
ber of presumably metabolically activating states in nor-
mal awake humans such as the performance of calcula-
tions [25], reaction time tests [26], abstract thought [27]
or an omitted stimulus paradigm [28]. The frontal local-
ization of the apparently positive correlation between del-
ta and PET also may be regarded as consistent with the
contention that this may be a valid reflection of physiolo-
gy and not accidental artifact. Such a contention receives
support from the putative role of the forebrain in the nor-
mal generation of delta power and from studies utilizing
dipole analysis that place the site of maximum delta gen-
eration in normals in the frontal cortex [27, 29].
The apparent phenomena whereby metabolism and
EEG appear to correlate more strongly in the presence of
ischemic or primary dementia injury than in the absence
of frank neurologic pathology [1–4] also suggest the possi-
bility that normal physiologic determinants of slow activi-
ty exist that are part of the normative frequency content
of the EEG and not of exclusively pathological origin.
This view appears to receive some support from the litera-
ture on normal controls and psychiatric patients. Okyere
et al. [30] reported a significant positive correlation of
qEEG amplitude, as opposed to frequency with CBF in
normals, and did not observe a significant relationship of
CBF to qEEG frequency. Modulations of qEEG ampli-
tudes by normal metabolism could produce changes in the
correlation of the spectral content of the qEEG with
metabolism in a way different from that which has been
reported for dementia. Metabolic modulation of qEEG
amplitude could be logically expected to permit the disso-
ciation of qEEG slowing from decreased metabolism and
could even possibly account for a positive correlation of
qEEG slow activity with metabolic activation.
The positive correlation of alpha power with subcorti-
cal metabolism may well be an epiphenomenon related to
neuroleptic medication. Reduced alpha power in schizo-
phrenia is a well replicated finding in the qEEG literature
[31]. Neuroleptic medication reportedly increases alpha
[32–35], and also subcortical metabolism [36]. The appar-
ently positive correlation between subcortical metabolism
and alpha power seen in this study may simply reflect
neuroleptic-related increases in both alpha power and
subcortical metabolism and not necessarily a direct causal
association.
The small number of subjects and the medicated state
of most of the patients are significant limitations of this
present study. Nonetheless, the correlation of metabolism
with EEG is an arguably interesting heuristic approach to
understanding the metabolic basis of the EEG. Logical
directions for extending the results presented here include
studying PET and EEG in normal subjects, medication-
free patients and of course independently replicating the
preliminary results on the small sample of patients pre-
sented here.
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